- By insider

CEO of Odonate Therapeutics Inc (ODT) Kevin C Tang bought 20,000 shares of ODT on 12/07/2018 at an average price of $14.79 a share. The total cost of this purchase was $295,800.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer. Odonate Therapeutics Inc has a market cap of $406.180 million; its shares were traded at around $15.14 .

• Warning! GuruFocus has detected 1 Warning Sign with ODT. Click here to check it out.

• ODT 15-Year Financial Data

• The intrinsic value of ODT

• Peter Lynch Chart of ODT

CEO Recent Trades:

• CEO, 10% Owner Kevin C Tang bought 20,000 shares of ODT stock on 12/07/2018 at the average price of $14.79. The price of the stock has increased by 2.37% since.

• CEO, 10% Owner Kevin C Tang bought 3,063 shares of ODT stock on 11/27/2018 at the average price of $15.64. The price of the stock has decreased by 3.2% since.

• CEO, 10% Owner Kevin C Tang bought 16,937 shares of ODT stock on 11/26/2018 at the average price of $15.29. The price of the stock has decreased by 0.98% since.

For the complete insider trading history of ODT, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 1 Warning Sign with ODT. Click here to check it out.

• ODT 15-Year Financial Data

• The intrinsic value of ODT

• Peter Lynch Chart of ODT